Delivery Order SPE2DB22D1202-SPE2DB24FUXC6

Award Date 4/15/24
Potential Completion Date 4/16/24
Potential Value $9.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,051.40 firm-fixed-price delivery order is for the supply of 40,000-unit capsules of the drug Zenpep. The contract has an ultimate completion date of April 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of pharmaceutical products and medical supplies. The contract has a ceiling value of $14,631.85 and is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,365.99 firm fixed-price delivery order is for the supply of 40,000 unit capsules of the drug ZENPEP. The contract has an ultimate completion date of December 12, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,930.14 firm fixed-price delivery order is for the supply of ZENPEP DR 60,000 UNIT CAPSULE 100S, a medication used to treat certain digestive conditions. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $9,267.00, is for the delivery of 4564878635 ! ZENPEP DR 25,000 UNIT CAPSULE 100S medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and a completion date of June 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,337.18 firm fixed-price delivery order is for the supply of 40,000-unit capsules of the drug ZENPEP. The contract has a completion date of September 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,581.94 firm fixed-price delivery order is for the supply of 4,565,549 units of the prescription drug ZENPEP (60,000 unit capsules), with a completion date of August 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop...
This federal contract award, valued at $27,032.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price contract. No set-aside designation was used for this award. AmerisourceBergen holds a...
This federal contract award, valued at $24,141.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (DO) under the broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award, valued at $17,481.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract provides for the delivery of ZENPEP DR 40,000 UNIT CAPSULE 100S, a pharmaceutical product, to...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUXC6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,267.00 fixed-price delivery order is for the supply of 4564286748 - ZENPEP DR 25,000 UNIT CAPSULE 100S, with a completion date of April 16, 2024.

Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 7/15/24, 6:45 PM